FDA
-
-
-
-
-
-
-
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
-
-
-
-
-
-
-
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2025 and Provides Conference Call Information
-
-
-
-
-
-
-
Elite Pharmaceuticals, Inc. (ELTP) Announces Commercial Launch of Generic Vyvanse
-
-
-
-
-
-
-
Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health
-
-
-
-
-
-
-
Elite Pharmaceuticals, Inc. (ELTP) Receives FDA Approval for Generic Methotrexate
-
-
-
-
-
-
-
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2020 Ended September 30, 2019 and Provides Conference Call Information
-
-
-
-
-
-
-
Elite Pharmaceuticals Inc. Reports Strategic Marketing Alliance with Lannett For Generic Adderall
-
325,127 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

